MDT

87.86

-1.21%↓

VEEV

221.66

-2.12%↓

A

109.71

-5.41%↓

HQY

82.88

-6.59%↓

PDCO

31.2

-0.22%↓

MDT

87.86

-1.21%↓

VEEV

221.66

-2.12%↓

A

109.71

-5.41%↓

HQY

82.88

-6.59%↓

PDCO

31.2

-0.22%↓

MDT

87.86

-1.21%↓

VEEV

221.66

-2.12%↓

A

109.71

-5.41%↓

HQY

82.88

-6.59%↓

PDCO

31.2

-0.22%↓

MDT

87.86

-1.21%↓

VEEV

221.66

-2.12%↓

A

109.71

-5.41%↓

HQY

82.88

-6.59%↓

PDCO

31.2

-0.22%↓

MDT

87.86

-1.21%↓

VEEV

221.66

-2.12%↓

A

109.71

-5.41%↓

HQY

82.88

-6.59%↓

PDCO

31.2

-0.22%↓

Search

Stryker Corp

Gesloten

SectorGezondheidszorg

368.07 -2.53

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

361.35

Max

377.22

Belangrijke statistieken

By Trading Economics

Inkomsten

-288M

546M

Verkoop

946M

6.4B

K/W

Sectorgemiddelde

48.094

63.778

EPS

4.01

Dividendrendement

0.9

Winstmarge

8.484

Werknemers

53,000

EBITDA

385M

1.8B

Aanbevelingen

By TipRanks

Aanbevelingen

Strong Buy

12 Maanden Prognose

+15.32% upside

Dividenden

By Dow Jones

Dividendrendement

Sectorgemiddelde

0.90%

2.39%

Volgende Winsten

29 apr 2025

Volgende dividenddatum

30 apr 2025

Marktinformatie

By TradingEconomics

Marktkapitalisatie

-8.2B

142B

Vorige openingsprijs

370.6

Vorige sluitingsprijs

368.07

Nieuwssentiment

By Acuity

28%

72%

83 / 386 Rangschikking in Healthcare

Technische score

By Trading Central

Vertrouwen

Strong Bullish Evidence

Stryker Corp Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

28 jan 2025, 21:55 UTC

Winsten

Stryker Sees Further Organic Sales Growth in 2025

28 jan 2025, 21:46 UTC

Acquisities, Fusies, Overnames

Stryker to Sell Spinal Implants Business to Viscogliosi Brothers

6 jan 2025, 22:18 UTC

Acquisities, Fusies, Overnames

Stryker to Acquire Inari Medical in Deal Valued at $4.9 Billion -- Update

6 jan 2025, 21:39 UTC

Acquisities, Fusies, Overnames

Stryker to Acquire Inari Medical in Deal Valued at $4.9 Billion

19 feb 2025, 13:53 UTC

Acquisities, Fusies, Overnames

Stryker Files 8K - Asset Acquisition Or Disposition >SYK

19 feb 2025, 13:30 UTC

Acquisities, Fusies, Overnames

Stryker Completes Acquisition Of Inari Medical, Inc., Providing Entry Into The High-growth Peripheral Vascular Segment >SYK

28 jan 2025, 21:09 UTC

Acquisities, Fusies, Overnames

Stryker: Transaction Is Expected to Close in the U.S. in 1H 2025 >SYK

28 jan 2025, 21:09 UTC

Acquisities, Fusies, Overnames

Stryker: Agreement Includes Binding Offer to Acquire Stryker's Spinal Implants Business in France >SYK

28 jan 2025, 21:08 UTC

Acquisities, Fusies, Overnames

Stryker: After Closing, VB Spine Will Become a Strategic Partner to Stryker With Exclusive Access to Mako Spine and Copilot for Use With VB Spine's Implants in Spine Procedures >SYK

28 jan 2025, 21:08 UTC

Acquisities, Fusies, Overnames

Stryker: Agreement to Sell U.S. Spinal Implants Business to Viscogliosi Brothers, LLC to Create Newly Formed Co Called VB Spine, LLC >SYK

28 jan 2025, 21:06 UTC

Winsten

Stryker Sees Organic Net Sales Growth of 8% to 9% for 2025 >SYK

28 jan 2025, 21:06 UTC

Winsten

Stryker Sees FY Adj EPS $13.45-Adj EPS $13.70 >SYK

28 jan 2025, 21:05 UTC

Acquisities, Fusies, Overnames

Stryker: Announces Definitive Agreement for the Sale of U.S. Spinal Implants Business and Plans to Sell Related Intl Business

28 jan 2025, 21:05 UTC

Winsten

Stryker 4Q Net $500M >SYK

28 jan 2025, 21:05 UTC

Winsten

Stryker 4Q Adj EPS $4.01 >SYK

28 jan 2025, 21:05 UTC

Winsten

Stryker 4Q Net $546M >SYK

28 jan 2025, 21:05 UTC

Winsten

Stryker 4Q Net $500M >SYK

28 jan 2025, 21:05 UTC

Winsten

Stryker 4Q Sales $6.4B >SYK

28 jan 2025, 21:05 UTC

Winsten

Stryker 4Q EPS $1.41 >SYK

28 jan 2025, 21:05 UTC

Winsten

Stryker 4Q Adj EPS $4.01 >SYK

28 jan 2025, 21:05 UTC

Winsten

Stryker 4Q EPS $1.41 >SYK

28 jan 2025, 21:05 UTC

Winsten

Stryker 4Q Sales $6.4B >SYK

17 jan 2025, 21:20 UTC

Acquisities, Fusies, Overnames

Stryker Commences Tender Offer for All Outstanding Shrs of Common Stock of Inari Medical

13 jan 2025, 19:30 UTC

Winsten

Update: Stryker Had A Good Year Last Year; Here's How It's Looking For 2025 -- IBD

7 jan 2025, 09:58 UTC

Populaire aandelen

Stocks to Watch Tuesday: Nvidia, Uber, Tencent -- WSJ

6 jan 2025, 22:03 UTC

Top Nieuws
Acquisities, Fusies, Overnames

Stryker to Acquire Inari Medical in Deal Valued at $4.9B -- Update

6 jan 2025, 21:49 UTC

Acquisities, Fusies, Overnames

Inari Medical Catapults -- Again -- After Stryker Confirms $4.9 Billion Deal -- IBD

6 jan 2025, 21:24 UTC

Top Nieuws
Acquisities, Fusies, Overnames

Stryker to Acquire Inari Medical in Deal Valued at $4.9B

6 jan 2025, 21:11 UTC

Acquisities, Fusies, Overnames

Stryker: Inari's Innovative Pdt Portfolio Is Highly Complementary to Our Neurovascular Business >SYK

6 jan 2025, 21:10 UTC

Acquisities, Fusies, Overnames

Stryker: Transaction Is Anticipated to Close by the End of the 1Q >SYK

Peer Vergelijking

Prijswijziging

Stryker Corp Prognose

Koersdoel

By TipRanks

15.32% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 435.3 USD  15.32%

Hoogste 465 USD

Laagste 400 USD

Gebaseerd op 22 Wall Street-analisten die 12-maands prijsdoelen bieden voor Stryker Corp - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Strong Buy

22 ratings

18

Buy

4

Hold

0

Sell

Technische score

By Trading Central

374.61 / 378.05Steun & Weerstand

Korte Termijn

Strong Bullish Evidence

Gemiddeld Termijn

Bearish Evidence

Lange Termijn

Neutral Evidence

Sentiment

By Acuity

83 / 386 Rangschikking in Gezondheidszorg

Nieuwssentiment

Bullish Bewijs

Volatiliteit

Onder gemiddelde

Nieuws Volume (RCV)

Boven gemiddelde

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

$

Over Stryker Corp

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries. This segment also offers spinal implant products comprising cervical and thoracolumbar systems that include fixation, minimally invasive and interbody systems used in spinal injury, complex spine and degenerative therapies. The MedSurg and Neurotechnology segment offers surgical equipment, and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, clinical communication and workflow solutions, and other medical device products that are used in various medical specialties, as well as patient and caregiver safety technologies. This segment also provides neurosurgical, neurovascular and craniomaxillofacial implant products, which include products used for minimally invasive endovascular procedures; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke; and craniomaxillofacial implant products, including cranial, maxillofacial, and chest wall devices, as well as dural substitutes and sealants. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Portage, Michigan.